Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFN Beta-1b and Ribavirin for COVID-19
NCT04494399Phase 2Unknown
- Sponsor
- The University of Hong Kong
- Start
- Jul 2020
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands, Cytokines & Interferons, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1b, ribavirin in coronavirus disease 2019 (COVID-19), sponsored by The University of Hong Kong. Status: unknown.
02
Drugs
interferon beta-1bribavirin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04494399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04494399.